JI
JioBlackRock Sector Rotation Fund Direct Growth
Latest NAV
+0.00% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty 500 TRI
Expense ratio
0.85%
AUM
₹167 Cr
Min SIP
₹500
Min lump sum
₹500
1Y
+0.00%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
Feb 2026
Where the NAV sits & how risky it is
₹9.46
52-week range
at 46%
₹9.46
Low 30 Mar 2026₹8.82
High 03 Aug 2026₹10.20
Risk level
Very High
Low
Very high
NAV history
19 Feb 2026
Since inception
05 Oct 2026
Returns by period
1W
-2.98%
1M
-5.82%
3M
-5.40%
6M
+4.91%
1Y
+0.00%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹500
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. This scheme is too new to have a track record for any of those windows, so the calculator starts on a neutral custom rate — change it to whatever you assume.
Where your money goes
AS OF 31 MAY 2026
Equity 99.19%
Cash & other 1.90%
Sector split
Country split
Top 5 hold 23.4%
Top 10 hold 33.1%
302 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | HDFC Bank
INE040A01034 |
Financial Services Banks - Regional |
India |
6.31%
|
-22.07% |
| 2 | Reliance Industries
INE002A01018 |
Energy Oil & Gas Refining & Marketing |
India |
5.06%
|
-17.28% |
| 3 | ICICI Bank
INE090A01021 |
Financial Services Banks - Regional |
India |
5.02%
|
-0.16% |
| 4 | Bharti Airtel
INE397D01024 |
Communication Services Telecom Services |
India |
4.39%
|
-13.45% |
| 5 | Larsen & Toubro
INE018A01030 |
Industrials Engineering & Construction |
India |
2.65%
|
+0.09% |
| 6 | ITC
INE154A01025 |
Consumer Defensive Tobacco |
India |
2.36%
|
-25.66% |
| 7 | State Bank of India
INE062A01020 |
Financial Services Banks - Regional |
India |
2.24%
|
+5.32% |
| 8 | Axis Bank
INE238A01034 |
Financial Services Banks - Regional |
India |
2.06%
|
+6.85% |
| 9 | Kotak Bank
INE237A01036 |
Financial Services Banks - Regional |
India |
1.57%
|
-8.39% |
| 10 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
1.42%
|
+5.76% |
About this scheme
The investment objective of the Scheme is to generate long term capital appreciation by investing in equity and equity related instruments following sector rotation theme. There is no assurance that the investment objective of the Scheme will be achieved.
Fund manager(s): Tanvi Kacheria, Sahil Chaudhary
Exit load: No charges for withdrawal
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
13 Feb 2026
Lump-sum min
₹500
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 121.5 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 33.4 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 30.6 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 30.6 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 29.2 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 29.1 pts ahead of this fund